AIMS: To purify and characterize an antimicrobial protein (bacteriocin) isolated from the dairy product-derived Bacillus amyloliquefaciens. METHODS AND RESULTS: An unknown bacterial species cultured from the Yogu Farm probiotic dairy beverage was identified through 16S ribosomal RNA analysis as B. amyloliquefaciens, a phylogenetically close relative of Bacillus subtilis. The cell-free supernatant (CFS) of overnight cultures was active against Listeria monocytogenes and also against clinical isolates of Gardnerella vaginalis and Streptococcus agalactiae. At the same time, several isolates of vaginal probiotic Lactobacilli were resistant to the CFS. The nature of the compound causing inhibitory activity was confirmed as proteinaceous by enzymatic digestion. The protein was isolated using ammonium sulfate precipitation, and further purified via column chromatography. PCR analysis was conducted to determine relatedness to other bacteriocins produced by Bacillus spp. CONCLUSION: The antimicrobial protein isolated from B. amyloliquefaciens was shown to be subtilosin, a bacteriocin previously reported as produced only by B. subtilis. SIGNIFICANCE AND IMPACT OF THE STUDY: This is the first report of intra-species horizontal gene transfer for subtilosin and the first fully characterized bacteriocin isolated from B. amyloliquefaciens. Finally, this is the first report on subtilosin's activity against bacterial vaginosis-associated pathogens.
AIMS: To purify and characterize an antimicrobial protein (bacteriocin) isolated from the dairy product-derived Bacillus amyloliquefaciens. METHODS AND RESULTS: An unknown bacterial species cultured from the Yogu Farm probiotic dairy beverage was identified through 16S ribosomal RNA analysis as B. amyloliquefaciens, a phylogenetically close relative of Bacillus subtilis. The cell-free supernatant (CFS) of overnight cultures was active against Listeria monocytogenes and also against clinical isolates of Gardnerella vaginalis and Streptococcus agalactiae. At the same time, several isolates of vaginal probiotic Lactobacilli were resistant to the CFS. The nature of the compound causing inhibitory activity was confirmed as proteinaceous by enzymatic digestion. The protein was isolated using ammonium sulfate precipitation, and further purified via column chromatography. PCR analysis was conducted to determine relatedness to other bacteriocins produced by Bacillus spp. CONCLUSION: The antimicrobial protein isolated from B. amyloliquefaciens was shown to be subtilosin, a bacteriocin previously reported as produced only by B. subtilis. SIGNIFICANCE AND IMPACT OF THE STUDY: This is the first report of intra-species horizontal gene transfer for subtilosin and the first fully characterized bacteriocin isolated from B. amyloliquefaciens. Finally, this is the first report on subtilosin's activity against bacterial vaginosis-associated pathogens.
Authors: Charles E Shelburne; Florence Y An; Vishnu Dholpe; Ayyalusamy Ramamoorthy; Dennis E Lopatin; Marilyn S Lantz Journal: J Antimicrob Chemother Date: 2007-01-09 Impact factor: 5.790
Authors: Karen E Kawulka; Tara Sprules; Christopher M Diaper; Randy M Whittal; Ryan T McKay; Pascal Mercier; Peter Zuber; John C Vederas Journal: Biochemistry Date: 2004-03-30 Impact factor: 3.162
Authors: Ammar Algburi; Halah M Al-Hasani; Thurya K Ismael; Alyaa Abdelhameed; Richard Weeks; Aleksey M Ermakov; Michael L Chikindas Journal: Probiotics Antimicrob Proteins Date: 2021-02 Impact factor: 4.609
Authors: Clarisse Roblin; Steve Chiumento; Olivier Bornet; Matthieu Nouailler; Christina S Müller; Katy Jeannot; Christian Basset; Sylvie Kieffer-Jaquinod; Yohann Couté; Stéphane Torelli; Laurent Le Pape; Volker Schünemann; Hamza Olleik; Bruno De La Villeon; Philippe Sockeel; Eric Di Pasquale; Cendrine Nicoletti; Nicolas Vidal; Leonora Poljak; Olga Iranzo; Thierry Giardina; Michel Fons; Estelle Devillard; Patrice Polard; Marc Maresca; Josette Perrier; Mohamed Atta; Françoise Guerlesquin; Mickael Lafond; Victor Duarte Journal: Proc Natl Acad Sci U S A Date: 2020-07-27 Impact factor: 11.205
Authors: Maria S Mazanko; Maksim S Makarenko; Vladimir A Chistyakov; Alexander V Usatov; Evgeniya V Prazdnova; Anzhelika B Bren; Ivan F Gorlov; Zoya B Komarova; Richard Weeks; Michael L Chikindas Journal: Probiotics Antimicrob Proteins Date: 2019-12 Impact factor: 4.609